{"id":378031,"date":"2024-05-22T14:00:00","date_gmt":"2024-05-22T12:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=378031"},"modified":"2024-05-22T14:00:00","modified_gmt":"2024-05-22T12:00:00","slug":"agonista-duplo-do-recetor-gip-glp-1-como-opcao-terapeutica-inovadora","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/agonista-duplo-do-recetor-gip-glp-1-como-opcao-terapeutica-inovadora\/","title":{"rendered":"Agonista duplo do recetor GIP\/GLP-1 como op\u00e7\u00e3o terap\u00eautica inovadora"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":7,"featured_media":126780,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Diabetes tipo 2: tend\u00eancias actuais  ","footnotes":""},"category":[11397,11521,11524,11305,11551],"tags":[75354,19681,12023,23805,75355,75353,75352,75351,69485,74912],"powerkit_post_featured":[],"class_list":["post-378031","post","type-post","status-publish","format-standard","has-post-thumbnail","category-endocrinologia-e-diabetologia-2","category-estudos","category-formacao-continua","category-medicina-interna-geral","category-rx-pt","tag-agonista-duplo-do-recetor-gip-glp-1","tag-bpl-1","tag-diabetes-tipo-2-pt-pt","tag-gip-pt-pt","tag-mounjaro-pt-pt","tag-opcao-terapeutica-inovadora","tag-peptido-insulinotropico-dependente-da-glucose","tag-peptido-semelhante-ao-glucagon","tag-surpass-pt-pt","tag-terapias-baseadas-na-incretina","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-11 04:30:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":377975,"slug":"agonista-dual-de-los-receptores-gip-glp-1-como-opcion-terapeutica-innovadora","post_title":"Agonista dual de los receptores GIP\/GLP-1 como opci\u00f3n terap\u00e9utica innovadora","href":"https:\/\/medizinonline.com\/es\/agonista-dual-de-los-receptores-gip-glp-1-como-opcion-terapeutica-innovadora\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/378031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=378031"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/378031\/revisions"}],"predecessor-version":[{"id":379622,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/378031\/revisions\/379622"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/126780"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=378031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=378031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=378031"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=378031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}